Hyftor Alternatives Compared
| Hyftor (sirolimus) | Everolimus | Afinitor (everolimus) |
|
|---|
| Hyftor (sirolimus) | Everolimus | Afinitor (everolimus) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Angiofibroma, Tuberous Sclerosis Complex. Hyftor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Breast Cancer, Tuberous Sclerosis Complex, Brain Tumor, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Angiomyolipoma, Renal Cell Carcinoma... View more |
Prescription only
Afinitor (everolimus) is a targeted medicine that may be used to treat various cancers and TSC-associated conditions. It reduces the blood supply to the cancers which slows down their growth and... View more |
Related suggestions Tuberous Sclerosis Complex
|
|||||||||||||||||||||||
| More about Hyftor (sirolimus) | More about Everolimus | More about Afinitor (everolimus) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Everolimus has an average rating of 5.6 out of 10 from a total of 29 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 38% reported a negative effect. |
Afinitor has an average rating of 5.4 out of 10 from a total of 20 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Hyftor side effects |
View all Everolimus side effects |
View all Afinitor side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Hyftor prices |
View all Everolimus prices |
View all Afinitor prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Afinitor, Afinitor Disperz, Torpenz, Zortress | Other everolimus brands include: Afinitor Disperz, Torpenz, Zortress | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
78 hours |
35 hours |
35 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 162 drugs are known to interact with Hyftor:
|
A total of 544 drugs are known to interact with Everolimus:
|
A total of 544 drugs are known to interact with Afinitor:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 22, 2022 |
March 30, 2009 |
March 30, 2009 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.